PSES Helps in Detecting Castration-Resistant Prostate Cancer
Researchers from University of California, Los Angeles, have come up with a new way of diagnosing serious forms of prostate cancer. This is an advanced form of detection for the disease and better than that of the traditional detection mode.
The device will help the oncologists to provide the sufferer with an early treatment resulting in increasing the chances of surviving from the disease. The researchers have developed a genetic form of imaging system, which detects prostate cancer which was dead against androgen deprivation therapy.
This form of prostate cancer is known as Castration Resistant Prostate Cancer (CRPC). According to Lily Wu, "Unfortunately, there is little that can be done to treat castration resistant prostate cancer once it has spread. In our study, we focused on finding ways to image these advanced metastatic prostate cancers accurately".
The researchers were trying to use the regulating knob of the gene prostate specific enhancing sequence (PSES) that was capable to work on castration resistant prostate cancer. The PSES is channelized to those components of gene, which can be easily imaged by the advanced device. The reporter knob can be detected under the bioluminescent or positron emission tomography (PET) scanning. The researchers were astonished to find the successful working of PSES on this form of cancer.
United Kingdom News
- UK electric car adoption pace not quick enough to meet government targets: Study
- Honda, KTM, Piaggio & Yamaha set up swappable battery consortium
- ACC to receive €437 million to build battery gigafactory
- European plug-in car registrations jump 237% year-over-year in Q2 2021
- Zapp i300 e-scooter available in Germany, with price tag of €6,300